Patent details

EP2272825 Title: Protected amino hydroxy adamantane carboxylic acid and process for its preparation

  • Data
  • Documents

Basic Information

Publication number:
EP2272825
PCT Application Number:
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP101789071
PCT Publication Number:
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
Protected amino hydroxy adamantane carboxylic acid and process for its preparation
French Title of Invention:
Acide amino-hydroxy-adamantane-carboxylique protégé et procédé pour sa préparation
German Title of Invention:
Geschützte Amino-hydroxy-adamantan-carbonsäure und Verfahren zu ihrer Herstellung
SPC Number:

Dates

Filing date:
05/03/2001
Grant date:
04/11/2015
EP Publication Date:
04/11/2015
PCT Publication Date:
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
12/01/2011
EP B1 Publication Date:
04/11/2015
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
05/03/2016
Expiration date:
05/03/2021
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
05/03/2001
 
 

Name:
AstraZeneca AB
Address:
-, 151 85 Södertälje, Sweden (SE)

Inventor

1

Name:
Sulsky Richard B.
Address:
United States (US)

2

Name:
Magnin David R.
Address:
United States (US)

3

Name:
Robl Jeffrey A.
Address:
United States (US)

4

Name:
Hamann Lawrence G.
Address:
United States (US)

5

Name:
Betebenner David A.
Address:
United States (US)

6

Name:
Augeri David J.
Address:
United States (US)

Priority

Priority Number:
188555 P
Priority Date:
10/03/2000
Priority Country:
United States (US)

Classification

Main IPC Class:
C07C 271/22;
Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer: